CRMD vs GYRE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 10, 2026
CRMD
GYRE
Investment Advisor Scores
GYRE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CRMD | GYRE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 44.4444 | 78.125 | CRMD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 156.5% | -2.1% | CRMD |
| Earnings Growth | 6.7% | 166.2% | GYRE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.7/100 | 44.3/100 | GYRE |
| Profit Margin | 40.5% | -19.3% | CRMD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | GYRE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CRMD
DistributionPrice near a flattening SMA50 (slope -1.1%) with fading momentum, RSI 43
GYRE
MarkupPrice above SMA50, rising 50-day trend (3.7% over 20 days), RSI 52
Fundamentals Snapshot
| Metric | CRMD | GYRE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 130.4 | -28.6 |
| Trailing P/E | 3.7 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.6% | 0.0% |
| Gross Margin | 0.9% | 0.9% |
| Operating Margin | 0.4% | -0.5% |
| EPS | 2.14 | -0.20 |
| Dividend Yield | — | — |